UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 103

Sortiert nach

BglBrick vectors and datasheets: A synthetic biology platform for gene expression

Journal of biological engineering, 2011-09, Vol.5 (1), p.12-12, Article 12

2011

Volltextzugriff (PDF)

The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer

Clinical cancer research, 2016-03, Vol.22 (6), p.1510-1519

2016

Volltextzugriff (PDF)

Targeted proteomics for metabolic pathway optimization: Application to terpene production

Metabolic engineering, 2011-03, Vol.13 (2), p.194-203

2011

Volltextzugriff (PDF)

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

BMC cancer, 2016-09, Vol.16 (1), p.744-744, Article 744

2016

Volltextzugriff (PDF)

Identification of human embryonic progenitor cell targeting peptides using phage display

PloS one, 2013-03, Vol.8 (3), p.e58200

2013

Volltextzugriff (PDF)

Selection of Phage Display Peptides Targeting Human Pluripotent Stem Cell-Derived Progenitor Cell Lines

Methods in molecular biology (Clifton, N.J.), 2016-01, Vol.1357, p.269

2016

Volltextzugriff (PDF)

Androgen receptor expression on circulating tumor cells in metastatic breast cancer

PloS one, 2017-09, Vol.12 (9), p.e0185231-e0185231

2017

Volltextzugriff (PDF)

Development of an immunofluorescent AR-V7 circulating tumor cell assay - A blood-based test for men with metastatic prostate cancer

Journal of circulating biomarkers, 2020, Vol.9 (1), p.13-19

2020

Volltextzugriff (PDF)

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

Cancer research (Chicago, Ill.), 2017-10, Vol.77 (20), p.5687-5698

2017

Volltextzugriff (PDF)

Quantification of activated and exhausted immune cell populations and simultaneous characterization of circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14033-e14033

2019

Volltextzugriff (PDF)

Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival

Cancer epidemiology, biomarkers & prevention, 2017-07, Vol.26 (7), p.1139-1145

2017

Volltextzugriff (PDF)

Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells

Journal of circulating biomarkers, 2015-01, Vol.4, p.4-4

2015

Volltextzugriff (PDF)

Phenotypic diversity of circulating tumour cells in patients with metastatic castration‐resistant prostate cancer

BJU international, 2017-11, Vol.120 (5B), p.E30-E44

2017

Volltextzugriff (PDF)

Abstract 4039: Simultaneous quantification of activated immune cells and PD-L1 expressing circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4039-4039

2019

Volltextzugriff (PDF)

Circulating cellular biomarkers associated with delayed time to progression among bladder cancer patients treated with immune checkpoint inhibitors

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.398-398

2019

Volltextzugriff (PDF)

Abstract 683: Quantification of rare PD-L1 expressing leukocytes and CTCs in peripheral blood of cancer patients

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.683-683

2017

Volltextzugriff (PDF)

Abstract 5536: Simultaneous characterization and quantification of immune cell subpopulations and PD-L1 expressing CTCs in peripheral blood of cancer patients

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5536-5536

2018

Volltextzugriff (PDF)

Detection of glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) from patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5046-5046

2016

Volltextzugriff (PDF)

Abstract 2841: Characterization of ALK fusions in circulating tumor cells (CTCs) of NSCLC

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2841-2841

2014

Volltextzugriff (PDF)

Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.198-198

2014

Volltextzugriff (PDF)

Characterization of programmed cell death-1 ligand (PD-L1) expression in circulating tumor cells (CTCs) of lung cancer

Journal of thoracic oncology, 2016-02, Vol.11 (2), p.S52-S52

2016

Volltextzugriff (PDF)

Abstract 496: Androgen receptor expression on circulating tumor cells in metastatic breast cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.496-496

2016

Volltextzugriff (PDF)

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4527-4527

2016

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(101)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(103)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(38)
Humans
(32)
Female
(17)
Male
(17)
Adult
(13)
Middle Aged
(13)
Aged
(10)
Nutrition & Dietetics
(10)
Oncology
(10)
Biomarkers
(8)
Obesity
(8)
Surgery
(8)
Weight Loss
(8)
Diet
(6)
Energy Intake
(6)
Food
(6)
Metastasis
(6)
Body Mass Index
(5)
Neoplastic Cells, Circulating - Pathology
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

BglBrick vectors and datasheets: A synthetic biology platform for gene expression

The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer

Targeted proteomics for metabolic pathway optimization: Application to terpene production

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Identification of human embryonic progenitor cell targeting peptides using phage display

Selection of Phage Display Peptides Targeting Human Pluripotent Stem Cell-Derived Progenitor Cell Lines

Androgen receptor expression on circulating tumor cells in metastatic breast cancer

Development of an immunofluorescent AR-V7 circulating tumor cell assay - A blood-based test for men with metastatic prostate cancer

Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer

Quantification of activated and exhausted immune cell populations and simultaneous characterization of circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy

Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival

Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells

Phenotypic diversity of circulating tumour cells in patients with metastatic castration‐resistant prostate cancer

Abstract 4039: Simultaneous quantification of activated immune cells and PD-L1 expressing circulating tumor cells (CTCs) in peripheral blood of cancer patients receiving checkpoint inhibitor therapy

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer

Circulating cellular biomarkers associated with delayed time to progression among bladder cancer patients treated with immune checkpoint inhibitors

Abstract 683: Quantification of rare PD-L1 expressing leukocytes and CTCs in peripheral blood of cancer patients

Abstract 5536: Simultaneous characterization and quantification of immune cell subpopulations and PD-L1 expressing CTCs in peripheral blood of cancer patients

Circulating Tumor Cell Subtypes and T-cell Population as Prognostic Biomarkers to Combination Immunotherapy in Metastatic Genitourinary Cancer Patients

Detection of glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) from patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Abstract 2841: Characterization of ALK fusions in circulating tumor cells (CTCs) of NSCLC

Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)

Characterization of programmed cell death-1 ligand (PD-L1) expression in circulating tumor cells (CTCs) of lung cancer

Abstract 496: Androgen receptor expression on circulating tumor cells in metastatic breast cancer

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients

Suchergebnisse filtern